Fidelity Investments’s Eterna Therapeutics ERNA Stock Holding History

Fidelity Investments’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	–	–	5377
2025 Q1	–	Hold	0	–	–	–	5408
2024 Q1	–	Hold	0	–	-$2	–	5472
2023 Q4	–	Hold	0	–	–	–	5397
2023 Q3	–	Hold	0	–	–	–	5244
2023 Q2	–	Hold	0	–	–	–	5337
2023 Q1	–	Hold	0	–	–	–	5219
2022 Q4	–	Hold	0	–	–	–	5306
2022 Q3	–	Sell	-2	Closed	-$6.89K	–	4997
2022 Q2	$6K	Buy	+2	New	+$14.4K	﹤0.01%	4249
2022 Q1	–	Hold	0	–	–	–	4422
2021 Q4	–	Hold	0	–	–	–	4498
2021 Q3	–	Hold	0	–	–	–	4523
2021 Q2	–	Hold	0	–	–	–	4411

Other funds holding ERNA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SCA

Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fidelity Investments's ERNA Position: Q2 2025 in Review

Fidelity Investments held its Eterna Therapeutics (ERNA) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5377.

Fidelity Investments first reported a position in ERNA in Q2 2022 and has held it in 1 quarter since. The position peaked at $6K in Q2 2022. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

Fidelity Investments held 0 shares of Eterna Therapeutics worth $0 as of Q2 2025.
Fidelity Investments left its Eterna Therapeutics share count unchanged in Q2 2025.
Eterna Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2025, its #5377 holding.
Fidelity Investments first reported a position in Eterna Therapeutics in Q2 2022 and has held it in 1 quarter since.
Fidelity Investments's Eterna Therapeutics position peaked at $6K in Q2 2022.
9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.